Peripheral Arterial Disease (PAD) is a chronic condition generated by the narrowing of arteries, which reduces the normal blood flow and triggers a wide range of manifestations mostly in the lower limbs, from chronic pain to critical limb ischemia. PAD’s progression can lead to chronic wounds, gangrene, amputation, and in most severe cases, death. While being a life-threatening disease affecting 200 million people in the world (40.5 million only in the EU) and the third cause of cardiovascular morbidity worldwide, there is no current solution able to target the broad range of symptoms and complications related to PAD.
AuriMod is a wearable device for non-invasive auricular stimulation of the vagus nerve which is the major constituent of the parasympathetic nervous system. It is capable of treating all symptoms of PAD, avoiding conventional drugs’ side effects and preventing complications including chronic wounds and consequent amputations. Applied to the patient’s ear, AuriMod sends specific electrical stimulation to the auricular branches of the vagus nerve, delivering a patient-tailored therapy that can effectively improve the quality of life of PAD patients.